TBIO


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue
us-gaap:StatementEquityComponents
us-gaap:SharesOutstanding

us-gaap:CommonStockSharesIssued
us-gaap:SubsidiarySaleOfStock

us-gaap:CommonStockSharesAuthorized

us-gaap:PreferredStockSharesAuthorized

us-gaap:CommonStockSharesOutstanding

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities, us-gaap:Range
us-gaap:Range, us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:OperatingExpenses

us-gaap:ResearchAndDevelopmentExpense
us-gaap:TypeOfArrangement

us-gaap:GeneralAndAdministrativeExpense

us-gaap:OperatingIncomeLoss

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeTaxExpenseBenefit
us-gaap:BusinessAcquisition

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:Assets

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:ShortTermInvestments

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
us-gaap:BusinessAcquisition
us-gaap:AmortizationOfIntangibleAssets

us-gaap:PropertyPlantAndEquipmentNet
us-gaap:BusinessAcquisition
us-gaap:Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType
us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:BusinessAcquisition

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherAssetsNoncurrent

us-gaap:LiabilitiesCurrent

us-gaap:AccountsPayableCurrent

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
us-gaap:SubsequentEventType, dei:LegalEntity
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:TypeOfArrangement

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:DepreciationDepletionAndAmortization

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
us-gaap:TypeOfArrangement
tbio:AdditionalUpfrontPayment

tbio:CashPaymentOfResearchAndDevelopmentExpense
us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement, tbio:CollaborativeAgreement
tbio:CollaborativeArrangementMilestonePayment

tbio:IncreaseDecreaseInLeaseLiability

tbio:IncreaseDecreaseInRightOfUseAssets

tbio:IncreaseDecreaseInShortTermCollaborationReceivables
us-gaap:TypeOfArrangement
tbio:PaymentsOfAnnualLicenseMaintenanceFees
us-gaap:TypeOfArrangement
tbio:StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement
us-gaap:StatementEquityComponents
tbio:StockIssuedDuringPeriodSharesNewIssuesPublicOffering

tbio:StockIssuedDuringPeriodValueNewIssuesPublicOffering
us-gaap:StatementEquityComponents

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
us-gaap:ContingentConsiderationByType

us-gaap:CapitalExpendituresIncurredButNotYetPaid
us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerLiabilityRevenueRecognized

us-gaap:Depreciation

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:InvestmentIncomeInterest

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
us-gaap:StatementEquityComponents
tbio:AgreementType
us-gaap:PaymentsOfStockIssuanceCosts
us-gaap:SubsidiarySaleOfStock
tbio:AgreementType
us-gaap:ProceedsFromIssuanceOfCommonStock
us-gaap:SubsidiarySaleOfStock

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities

us-gaap:ProceedsFromStockOptionsExercised
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock
us-gaap:SaleOfStockConsiderationReceivedOnTransaction
us-gaap:SubsidiarySaleOfStock, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock
us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
us-gaap:SubsidiarySaleOfStock, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:TitleOfIndividual, us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
us-gaap:TitleOfIndividual, us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap:StatementEquityComponents
us-gaap:IncomeStatementLocation
us-gaap:StockIssuedDuringPeriodValueIssuedForServices

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap:StatementEquityComponents

tbio:AccruedConsultantAndProfessionalFees

tbio:AccruedExternalResearchAndDevelopmentExpensesCurrent
us-gaap:TypeOfArrangement
tbio:AdditionalFeePerAddedPathogenOption
us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement, tbio:AgreementOne, dei:LegalEntity
tbio:AdditionalUpfrontPaymentReceivable
us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement, tbio:AgreementOne, tbio:SpecificAdditionalMilestonePayment, dei:LegalEntity

tbio:EquityAndDebtSecuritiesAuthorised
dei:LegalEntity
tbio:MaximumNumberOfInfectiousDisease
tbio:AgreementType, us-gaap:Range
tbio:SaleOfStockAuthorizedAmount
us-gaap:Range, tbio:AgreementType

tbio:ShortTermCollaborationReceivablesCurrent
us-gaap:TypeOfArrangement, dei:LegalEntity
tbio:UpfrontPaymentsReceived
us-gaap:ContingentConsiderationByType
us-gaap:AlternativeInvestmentMeasurementInput
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency

us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
us-gaap:PlanName
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiabilityNoncurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType
us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:BusinessAcquisition

us-gaap:IntangibleAssetsGrossExcludingGoodwill
us-gaap:ContingentConsiderationByType
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:ContingentConsiderationByType, us-gaap:MeasurementInputType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:MeasurementInputType, us-gaap:ContingentConsiderationByType

us-gaap:RestrictedCashCurrent
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock
us-gaap:SaleOfStockPricePerShare
us-gaap:SubsequentEventType, dei:LegalEntity
us-gaap:SubsidiarySaleOfStock
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
us-gaap:RelatedPartyTransactionsByRelatedParty

Tables

  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:CommonStockValue █▅▅▅▃▁▁▁0.0690.060.060.060.0510.0450.0450.045
 us-gaap:SharesOutstanding us-gaap:StatementEquityComponents us-gaap:CommonStock█▅▅▅▃▁▁▁69.35950960.03766360.02206760.02072551.01036845.29443945.13995545.14209
us-gaap:CommonStockSharesIssued █▅▅▅▃▁▁▁69.35950960.03766360.02206760.02072551.01036845.29443945.13995545.14209
us-gaap:CommonStockSharesAuthorized ▄▄▄▄▄▄▄▄200.0200.0200.0200.0200.0200.0200.0200.0
us-gaap:PreferredStockSharesAuthorized ▄▄▄▄▄▄▄▄10.010.010.010.010.010.010.010.0
us-gaap:CommonStockSharesOutstanding █▅▅▅▃▁▁▁69.35950960.03766360.02206760.02072551.01036845.29443945.13995545.14209
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted █▁62.28229160.008217NA51.89115748.74962745.004521NA44.036206
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount NA10.98999NANANA8.180787NA6.531851
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities us-gaap:EmployeeStockOptionNA10.983227NANANA8.012029NA6.241584
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities us-gaap:RestrictedStockNA0.006763NANANA0.168758NA0.290267
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities,us-gaap:Range us-gaap:RestrictedStock,srt:WeightedAverageNA0.018507NA0.0994680.1479140.197696NA0.333473
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:Range,us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities srt:WeightedAverage,us-gaap:RestrictedStock0.00379NANANA0.147914NANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax █▃▃▁▁▂▁▁16.3194.6543.891.2661.1741.4741.1820.238
us-gaap:OperatingExpenses █▃▅▃▄▅▁▇52.9519.44535.62922.90129.36435.6798.4845.719
us-gaap:ResearchAndDevelopmentExpense █▅▆▃▃▃▃▁29.00221.43925.02617.29516.62517.42317.1712.933
us-gaap:GeneralAndAdministrativeExpense █▅▅▄▆▃▁▁8.6017.4587.3486.8817.856.5545.885.957
us-gaap:OperatingIncomeLoss ▃▇▄▅▄▃█▁-36.631-14.791-31.739-21.635-28.19-34.205-7.298-45.481
us-gaap:AllocatedShareBasedCompensationExpense █▄▃▃▄▂▁▁6.0143.1722.9262.8993.5491.9591.641.435
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest ▃▇▄▅▄▃█▁-36.288-14.282-31.036-21.227-27.832-33.684-6.476-45.17
us-gaap:IncomeTaxExpenseBenefit █████▇▇▁0.00.00.00.00.0-0.486-0.439-2.524
 us-gaap:IncomeTaxExpenseBenefit us-gaap:BusinessAcquisition tbio:ShiresMrtProgram▄▄0.00.0NANA0.00.5NANA
us-gaap:NetIncomeLoss ▂▆▃▅▄▃█▁-36.288-14.282-31.036-21.227-27.832-33.198-6.037-42.646
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:AccumulatedOtherComprehensiveIncome0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:CommonStock0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁█-36.288-14.282NA-21.227-27.832-33.198NA-42.646
us-gaap:ComprehensiveIncomeNetOfTax ▂▆▃▅▄▃█▁-36.603-14.168-30.974-21.118-27.613-33.043-5.764-42.722
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:Assets █▂▃▄▂▁▁▂454.278305.242336.201349.514302.549277.736287.651304.588
us-gaap:Liabilities ▇▁▇▃█▇▁▅182.885162.57182.665167.941186.852182.628162.356175.171
us-gaap:LiabilitiesAndStockholdersEquity █▂▃▄▂▁▁▂454.278305.242336.201349.514302.549277.736287.651304.588
us-gaap:StockholdersEquity █▃▃▄▂▁▂▂271.393142.672153.536181.573115.69795.108125.295129.417
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:AssetsCurrent █▃▄▄▂▁▂▂316.221169.194203.615217.761153.884128.857149.602166.319
us-gaap:CashAndCashEquivalentsAtCarryingValue █▃▂▃▂▂▁▁272.19397.46884.5898.9374.90462.43155.19938.864
us-gaap:ShortTermInvestments ▁▄▇▇▅▄▆█20.02957.627104.098111.23371.96160.15488.904122.236
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ▆▅█▄▄▂▁▁7.9186.9219.3916.6486.0695.2474.4744.194
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:PropertyPlantAndEquipmentGross █▆▅▃▃▂▁▁23.77621.70119.80117.32216.93216.21315.12814.475
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment █▇▆▅▄▃▂▁8.6227.927.2626.6426.0295.4424.8834.407
 us-gaap:AmortizationOfIntangibleAssets us-gaap:BusinessAcquisition tbio:OTCDeficiencyProgram█▂▃▁▁▁3.60.71.10.40.30.5NANA
us-gaap:PropertyPlantAndEquipmentNet █▆▄▂▂▂▁▁15.15413.78112.53910.6810.90310.77110.24510.068
 us-gaap:Goodwill us-gaap:BusinessAcquisition tbio:ShiresMrtProgram██████▁▁21.421.421.421.421.421.421.35921.359
us-gaap:IntangibleAssetsNetExcludingGoodwill ▁▂▂▂████81.2884.84485.53686.695105.63105.98106.445106.842
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:BusinessAcquisition,us-gaap:FiniteLivedIntangibleAssetsByMajorClass,us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType tbio:ShiresMrtProgram,us-gaap:InProcessResearchAndDevelopment,tbio:MrtProduct38.989NA43.245NANANANANA
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass,us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType,us-gaap:BusinessAcquisition us-gaap:InProcessResearchAndDevelopment,tbio:MrtProduct,tbio:ShiresMrtProgramNA42.55343.24544.40444.78NA45.595NA
us-gaap:OperatingLeaseRightOfUseAsset ▁▃▄▅▇█10.1310.26810.410.52710.6510.769NANA
us-gaap:OtherAssetsNoncurrent █▄▁10.1345.7962.752NANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:LiabilitiesCurrent █▆▆▄▃▂▂▁51.76641.10841.6725.26620.05716.76314.2879.959
us-gaap:AccountsPayableCurrent ▆▃█▁▁▂▂▁12.9126.29715.9683.4073.3474.1925.1683.111
us-gaap:OtherAccruedLiabilitiesCurrent █▁▂2.8970.1270.372NANA0.1310.7360.202
us-gaap:AccruedLiabilitiesCurrent █▃▃▅▃▂▂▁11.1267.4787.0728.7677.2466.4526.5475.806
us-gaap:OperatingLeaseLiabilityCurrent █▄▁0.6190.5730.53NANANANANA
us-gaap:ContractWithCustomerLiabilityCurrent ██▆▄▃▂▁▁27.10926.7618.112.6039.0155.7082.5721.042
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:OperatingLeaseLiabilityNoncurrent ▁▅█11.75111.93112.084NANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:StockholdersEquity █▃▃▄▂▁▂▂271.393142.672153.536181.573115.69795.108125.295129.417
us-gaap:CommonStockValue █▅▅▅▃▁▁▁0.0690.060.060.060.0510.0450.0450.045
us-gaap:AdditionalPaidInCapital █▄▄▄▂▁▁▁680.85515.535512.231509.294422.309374.113371.257369.614
us-gaap:RetainedEarningsAccumulatedDeficit ▁▂▃▄▅▆██-410.066-373.778-359.496-328.46-307.233-279.401-246.203-240.166
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▆█▇▇▆▄▃▁0.540.8550.7410.6790.570.3510.196-0.076
 us-gaap:StockIssuedDuringPeriodValueNewIssues us-gaap:SubsequentEventType,dei:LegalEntity us-gaap:SubsequentEvent,tbio:SanofiPasteurIncNANANANANANANANA
 us-gaap:StockIssuedDuringPeriodValueNewIssues us-gaap:TypeOfArrangement tbio:SecuritiesPurchaseAgreementNANANANANANANANA
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue █▁6.0143.172NA2.8992.7031.959NA1.434
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▂▂▂▂▃█-20.042-31.447-20.262-20.455-19.914-21.531-16.24427.692
us-gaap:NetCashProvidedByUsedInInvestingActivities ██▆▄▆▇█▁35.16244.265.9-39.611-12.34127.86632.592-122.043
us-gaap:NetCashProvidedByUsedInFinancingActivities █▁▁▅▃▁▁▆159.6050.0750.01284.09244.6530.897-0.013115.779
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect █▂▁▂▂▂▂▂174.72512.888-14.3524.02612.3987.23216.33521.428
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▂▂▂▂▃█-20.042-31.447-20.262-20.455-19.914-21.531-16.24427.692
us-gaap:NetIncomeLoss ▂▆▃▅▄▃█▁-36.288-14.282-31.036-21.227-27.832-33.198-6.037-42.646
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:AccumulatedOtherComprehensiveIncome0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:CommonStock0.0NANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁█-36.288-14.282NA-21.227-27.832-33.198NA-42.646
us-gaap:DepreciationDepletionAndAmortization █▃▃▂▂▂▂▁4.2661.3511.7810.9910.9351.0250.9180.5
us-gaap:ShareBasedCompensation █▄▃▃▄▂▁▁6.0143.1722.9262.8993.551.9591.641.435
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:NetCashProvidedByUsedInInvestingActivities ██▆▄▆▇█▁35.16244.265.9-39.611-12.34127.86632.592-122.043
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▇█▄▁▂▃▃▂2.1212.3251.2960.4480.7541.0391.0130.81
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
us-gaap:NetCashProvidedByUsedInFinancingActivities █▁▁▅▃▁▁▆159.6050.0750.01284.09244.6530.897-0.013115.779
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30

None

us-gaap:CommonStockValue

us-gaap:CommonStockValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69000.060000.060000.060000.051000.045000.045000.045000.010000.010000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.0

None

us-gaap:SharesOutstanding us-gaap:StatementEquityComponents

us-gaap:SharesOutstanding

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value69606060514545459.6319399.5827919.5827918.532723
Percentage of SharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesIssued


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69606060514545459.6319399.582791
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStockSharesIssued us-gaap:SubsidiarySaleOfStock

tbio:PublicOffering


None
Period End2020-06-30
Value5.681819
Percentage of CommonStockSharesIssued8.2

None

us-gaap:CommonStockSharesAuthorized

us-gaap:CommonStockSharesAuthorized


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-07-022018-06-302017-12-31
Value200200200200200200200200200236236
Percentage of CommonStockSharesAuthorized100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:PreferredStockSharesAuthorized

us-gaap:PreferredStockSharesAuthorized


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value10000000.010000000.010000000.010000000.010000000.010000000.010000000.010000000.00
Percentage of PreferredStockSharesAuthorized100.0100.0100.0100.0100.0100.0100.0100.00.0

None

us-gaap:CommonStockSharesOutstanding

us-gaap:CommonStockSharesOutstanding


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69606060514545459.6319399.582791
Percentage of CommonStockSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value6260514845449.1872079.0916517.7813987.676426
Percentage of WeightedAverageNumberOfShareOutstandingBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount


None
Period End2020-03-312019-03-312018-09-302018-03-312017-09-30
Value108.1807876.53185131123
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

us-gaap:EmployeeStockOption


None
Period End2020-03-312019-03-312018-09-302018-03-312017-09-30
Value108.0120296.2415845.7639361.462468
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount99.997.995.618.11.2

us-gaap:RestrictedStock


None
Period End2020-03-312019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value0.0067630.1687580.2902670.412040.4478030.6092590.846114
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount0.12.14.40.01.40.50.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities, us-gaap:Range

us-gaap:RestrictedStock, srt:WeightedAverage


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-30
Value0.0185070.0994680.1479140.1976960.3334730.412040.491140.654951
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount0.20.00.02.45.10.01.50.5

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:Range, us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

srt:WeightedAverage, us-gaap:RestrictedStock


None
Period End2020-06-302019-06-30
Value0.003790.147914
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount0.00.0

None

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value164.6543.891.2661.1741.4741.1820.238
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:OperatingExpenses

us-gaap:OperatingExpenses


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value5219352229358.4845292224201814
Percentage of OperatingExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax324.5417.8915.91808.92501.22420.6717.419209.70.00.00.00.00.00.0

None

us-gaap:ResearchAndDevelopmentExpense

us-gaap:ResearchAndDevelopmentExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value29212517161717121512121113
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax177.7460.7643.31366.11416.11182.01452.65434.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense us-gaap:TypeOfArrangement

tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value0.10.10.10.10.10.10.00.10.10.10.00.10.1
Percentage of ResearchAndDevelopmentExpense0.30.50.40.60.60.60.00.80.70.80.00.90.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.62.12.67.98.56.80.042.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement0.00.00.00.00.00.00.00.00.00.00.00.00.0

tbio:MitResearchAgreement


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312017-09-302017-06-30
Value0.30.30.00.20.20.20.30.30.30.30.30.3
Percentage of ResearchAndDevelopmentExpense1.01.40.01.21.21.11.72.32.02.32.72.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.86.40.015.817.013.625.4126.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax tbio:MitResearchAgreement0.00.00.00.00.00.00.00.00.00.00.00.0

tbio:RocheDiagnosticsCorporationMasterSupplyAgreement


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312017-09-302017-06-30
Value1.30.77.11.81.02.52.50.80.81.10.40.5
Percentage of ResearchAndDevelopmentExpense4.53.328.410.46.014.314.66.25.38.63.63.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.015.0182.5142.285.2169.6211.5336.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax tbio:RocheDiagnosticsCorporationMasterSupplyAgreement0.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:GeneralAndAdministrativeExpense

us-gaap:GeneralAndAdministrativeExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value8.6017.4587.3486.8817.856.5545.885.9575.9914.7794.6053.6073.125
Percentage of GeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax52.7160.2188.9543.5668.7444.6497.52502.90.00.00.00.00.0

None

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-36631000.0-14791000.0-31739000.0-21635000.0-28190000.0-34205000.0-7298000.0-45481000.0-29062000.0-22389000.0-24588000.0-20836000.0-18955000.0-14869000.0
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-224.5-317.8-815.9-1708.9-2401.2-2320.6-617.4-19109.70.00.00.00.00.00.0

None

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value6.0143.1722.9262.8993.5491.9591.641.4352.8751.3832.3770.5110.691
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax36.968.275.2229.0302.3132.9138.7602.90.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

us-gaap:GeneralAndAdministrativeExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1.9231.7181.5941.5982.2651.090.9760.7961.2040.6011.4840.1540.081
Percentage of AllocatedShareBasedCompensationExpense32.054.254.555.163.855.659.555.541.943.562.430.111.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.836.941.0126.2192.973.982.6334.50.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:GeneralAndAdministrativeExpense0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value4.0911.4541.3321.3011.2840.8690.6640.6391.6710.7820.8930.3570.61
Percentage of AllocatedShareBasedCompensationExpense68.045.845.544.936.244.440.544.558.156.537.669.988.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.131.234.2102.8109.459.056.2268.50.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-36288000.0-14282000.0-31036000.0-21227000.0-27832000.0-33684000.0-6476000.0-45170000.0-29003000.0-22312000.0-24552000.0-20764000.0-18803000.0
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-222.4-306.9-797.8-1676.7-2370.7-2285.2-547.9-18979.00.00.00.00.00.0

None

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value00000-486000.0-439000.0-2524000.0-1500000.0-1103000.0-8461000.0-2299000.0-870000.0
Percentage of IncomeTaxExpenseBenefit0.00.00.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.0-33.0-37.1-1060.50.00.00.00.00.0

us-gaap:IncomeTaxExpenseBenefit us-gaap:BusinessAcquisition

tbio:ShiresMrtProgram


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value000500000.0
Percentage of IncomeTaxExpenseBenefit0.00.00.0-102.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.033.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax tbio:ShiresMrtProgram0.00.00.00.0

None

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-36288000.0-14282000.0-31036000.0-21227000.0-27832000.0-33198000.0-6037000.0-42646000.0-27503000.0-21209000.0-16091000.0-18465000.0-17933000.0-13954000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-222.4-306.9-797.8-1676.7-2370.7-2252.2-510.7-17918.50.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AdditionalPaidInCapital0.0

us-gaap:CommonStock


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CommonStock0.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-36288000.0-14282000.0-21227000.0-27832000.0-33198000.0-42646000.0-27503000.0-21209000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-222.4-306.9-1676.7-2370.7-2252.2-17918.50.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.0

None

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-36603000.0-14168000.0-30974000.0-21118000.0-27613000.0-33043000.0-5764000.0-42722000.0-27503000.0-21288000.0-16122000.0-18432000.0-17888000.0
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-224.3-304.4-796.2-1668.1-2352.0-2241.7-487.6-17950.40.00.00.00.00.0

None

us-gaap:Assets

us-gaap:Assets


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value454305336349302277287304166198
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:Liabilities

us-gaap:Liabilities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value18216218216718618216217511199
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets40.353.354.348.061.865.856.457.566.949.9

None

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value454305336349302277287304166198
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value27114215318111595125129-138.414-113.605-93.515-38.59
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets59.746.745.752.038.234.243.642.5-83.20.0-47.10.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value0.540.8550.7410.6790.570.3510.196-0.0760.079
Percentage of StockholdersEquity0.20.60.50.40.50.40.2-0.1-0.1
Percentage of Assets0.10.30.20.20.20.10.1-0.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value68051551250942237437136959565543
Percentage of StockholdersEquity250.9361.3333.6280.5365.0393.4296.3285.6-42.7-49.6-59.0-113.4
Percentage of Assets149.9168.9152.4145.7139.6134.7129.1121.335.50.027.80.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value0.0690.060.060.060.0510.0450.0450.0450.010.010.010.009
Percentage of StockholdersEquity0.00.00.00.00.00.00.00.0-0.0-0.0-0.0-0.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value-410.066-373.778-359.496-328.46-307.233-279.401-246.203-240.166-197.52-170.017-148.808-82.365
Percentage of StockholdersEquity-151.1-262.0-234.1-180.9-265.5-293.8-196.5-185.6142.7149.7159.1213.4
Percentage of Assets-90.3-122.5-106.9-94.0-101.5-100.6-85.6-78.8-118.80.0-74.90.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value3161692032171531281491662463
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets69.655.460.662.350.946.452.054.614.631.7

None

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value272978498746255381630486.4586.025
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets59.931.925.228.324.822.519.212.89.90.024.20.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel2


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value191535648175223241128
Percentage of CashAndCashEquivalentsAtCarryingValue70.355.266.949.423.584.642.262.367.359.5
Percentage of Assets42.117.616.814.05.819.08.17.96.714.4
Percentage of Assets us-gaap:MoneyMarketFunds us-gaap:FairValueInputsLevel20.00.00.00.00.00.00.00.00.00.0

None

us-gaap:ShortTermInvestments

us-gaap:ShortTermInvestments


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value20571041117160881221.09.997
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.418.931.031.823.821.730.940.10.65.0

None

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value7918000.06921000.09391000.06648000.06069000.05247000.04474000.04194000.04826000.03014000.0
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.72.32.81.92.01.91.61.42.91.5

None

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:PropertyPlantAndEquipmentGross


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value2321191716161514139.834
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.27.15.95.05.65.85.34.88.35.0

us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType

tbio:LaboratoryEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value109.79.0448.7888.3947.7577.0125.9515.9145.382
Percentage of PropertyPlantAndEquipmentGross44.244.745.750.749.647.846.441.142.854.7
Percentage of Assets2.33.22.72.52.82.82.42.03.62.7
Percentage of Assets tbio:LaboratoryEquipment0.00.00.00.00.00.00.00.00.00.0

us-gaap:ComputerEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value0.8930.8930.7790.780.780.7310.6860.6680.6260.481
Percentage of PropertyPlantAndEquipmentGross3.84.13.94.54.64.54.54.64.54.9
Percentage of Assets0.20.30.20.20.30.30.20.20.40.2
Percentage of Assets us-gaap:ComputerEquipment0.00.00.00.00.00.00.00.00.00.0

us-gaap:ConstructionInProgress


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value5.8654.593.461.2371.2411.2550.9591.4030.952.591
Percentage of PropertyPlantAndEquipmentGross24.721.217.57.17.37.76.39.76.926.3
Percentage of Assets1.31.51.00.40.40.50.30.50.61.3
Percentage of Assets us-gaap:ConstructionInProgress0.00.00.00.00.00.00.00.00.00.0

us-gaap:LeaseholdImprovements


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value5.6355.6355.6355.6345.6345.6345.6355.6345.6321.131
Percentage of PropertyPlantAndEquipmentGross23.726.028.532.533.334.737.238.940.711.5
Percentage of Assets1.21.81.71.61.92.02.01.83.40.6
Percentage of Assets us-gaap:LeaseholdImprovements0.00.00.00.00.00.00.00.00.00.0

us-gaap:OfficeEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value0.8830.8830.8830.8830.8830.8360.8360.8190.7010.249
Percentage of PropertyPlantAndEquipmentGross3.74.14.55.15.25.25.55.75.12.5
Percentage of Assets0.20.30.30.30.30.30.30.30.40.1
Percentage of Assets us-gaap:OfficeEquipment0.00.00.00.00.00.00.00.00.00.0

None

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value8622000.07920000.07262000.06642000.06029000.05442000.04883000.04407000.03955000.03056000.0
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.92.62.21.92.02.01.71.42.41.5

None

us-gaap:AmortizationOfIntangibleAssets us-gaap:BusinessAcquisition

us-gaap:AmortizationOfIntangibleAssets

tbio:OTCDeficiencyProgram


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312019-01-312019-01-01
Value3600000.0700000.01100000.0400000.0300000.0500000.000
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.00.00.0
Percentage of Assets0.00.00.00.00.00.00.00.0
Percentage of Assets tbio:OTCDeficiencyProgram0.00.00.00.00.00.00.00.0

None

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value15131210101010109.8686.778
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.34.53.73.13.63.93.63.35.93.4

None

us-gaap:Goodwill us-gaap:BusinessAcquisition

us-gaap:Goodwill

tbio:ShiresMrtProgram


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value212121212121212121
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.77.06.46.17.17.77.47.012.8
Percentage of Assets tbio:ShiresMrtProgram0.00.00.00.00.00.00.00.00.0

None

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value81848586105105106106106106
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets17.927.825.424.834.938.237.035.164.253.8

None

us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType

us-gaap:FiniteLivedIntangibleAssetsNet

tbio:ShiresMrtProgram, us-gaap:InProcessResearchAndDevelopment, tbio:MrtProduct


None
Period End2020-06-302019-12-31
Value3843
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0
Percentage of Assets8.612.9
Percentage of Assets tbio:ShiresMrtProgram us-gaap:InProcessResearchAndDevelopment tbio:MrtProduct0.00.0

us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:BusinessAcquisition

us-gaap:InProcessResearchAndDevelopment, tbio:MrtProduct, tbio:ShiresMrtProgram


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value4243444445
Percentage of FiniteLivedIntangibleAssetsNet0.0100.00.00.00.0
Percentage of Assets13.912.912.714.815.9
Percentage of Assets us-gaap:InProcessResearchAndDevelopment tbio:MrtProduct tbio:ShiresMrtProgram0.00.00.00.00.0

None

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value101010101010
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.0
Percentage of Assets2.23.43.13.03.53.9

None

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


None
Period End2020-06-302020-03-312019-12-31
Value105.7962.752
Percentage of OtherAssetsNoncurrent100.0100.0100.0
Percentage of Assets2.21.90.8

None

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value514141252016149.9591412
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets11.413.512.47.26.66.05.03.38.66.1

None

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value126.297153.4073.3474.1925.1683.1116.2194.594
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.82.14.71.01.11.51.81.03.72.3

None

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherAccruedLiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-03-312018-12-312018-09-302018-06-302017-12-31
Value2897000.0127000.0372000.0131000.0736000.0202000.0482000.01391000.0
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.60.00.10.00.30.10.30.7

None

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value117.4787.0728.7677.2466.4526.5475.8065.7585.888
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.42.42.12.52.42.32.31.93.53.0

None

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


None
Period End2020-06-302020-03-312019-12-31
Value619000.0573000.0530000.0
Percentage of OperatingLeaseLiabilityCurrent100.0100.0100.0
Percentage of Assets0.10.20.2

None

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value272618129.0155.7082.5721.042
Percentage of ContractWithCustomerLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.08.85.43.63.02.10.90.3

None

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


None
Period End2020-06-302020-03-312019-12-31
Value111112
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0100.0
Percentage of Assets2.63.93.6

None

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value27114215318111595125129-138.414-113.605-93.515-38.59
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets59.746.745.752.038.234.243.642.5-83.20.0-47.10.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value0.540.8550.7410.6790.570.3510.196-0.0760.079
Percentage of StockholdersEquity0.20.60.50.40.50.40.2-0.1-0.1
Percentage of Assets0.10.30.20.20.20.10.1-0.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value68051551250942237437136959565543
Percentage of StockholdersEquity250.9361.3333.6280.5365.0393.4296.3285.6-42.7-49.6-59.0-113.4
Percentage of Assets149.9168.9152.4145.7139.6134.7129.1121.335.50.027.80.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value0.0690.060.060.060.0510.0450.0450.0450.010.010.010.009
Percentage of StockholdersEquity0.00.00.00.00.00.00.00.0-0.0-0.0-0.0-0.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value-410.066-373.778-359.496-328.46-307.233-279.401-246.203-240.166-197.52-170.017-148.808-82.365
Percentage of StockholdersEquity-151.1-262.0-234.1-180.9-265.5-293.8-196.5-185.6142.7149.7159.1213.4
Percentage of Assets-90.3-122.5-106.9-94.0-101.5-100.6-85.6-78.8-118.80.0-74.90.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:CommonStockValue

us-gaap:CommonStockValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69000.060000.060000.060000.051000.045000.045000.045000.010000.010000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.0

None

us-gaap:AdditionalPaidInCapital

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value6805155125094223743713695955
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets149.9168.9152.4145.7139.6134.7129.1121.335.527.8

None

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value-410070000.0-373780000.0-359500000.0-328460000.0-307230000.0-279400000.0-246200000.0-240170000.0-197520000.0-148810000.0
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-90.3-122.5-106.9-94.0-101.5-100.6-85.6-78.8-118.8-74.9

None

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value540000.0855000.0741000.0679000.0570000.0351000.0196000.0-76000.079000.0
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.30.20.20.20.10.1-0.00.0

None

us-gaap:StockIssuedDuringPeriodValueNewIssues us-gaap:SubsequentEventType, dei:LegalEntity

us-gaap:StockIssuedDuringPeriodValueNewIssues

us-gaap:SubsequentEvent, tbio:SanofiPasteurInc


None
Period End2020-07-20
Value125
Percentage of StockIssuedDuringPeriodValueNewIssues100.0
Percentage of Assets0.0
Percentage of Assets us-gaap:SubsequentEvent tbio:SanofiPasteurInc0.0

us-gaap:StockIssuedDuringPeriodValueNewIssues us-gaap:TypeOfArrangement

tbio:SecuritiesPurchaseAgreement


None
Period End2020-07-20
Value125
Percentage of StockIssuedDuringPeriodValueNewIssues100.0
Percentage of Assets0.0
Percentage of Assets tbio:SecuritiesPurchaseAgreement0.0

None

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value6.0143.1722.8992.7031.9591.4342.8751.383
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-30
Value0.0
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue0.0
Percentage of Assets0.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value6.0143.1722.8992.7031.9591.4342.8751.383
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.0

us-gaap:CommonStock


None
Period End2020-06-30
Value0.0
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue0.0
Percentage of Assets0.0
Percentage of Assets us-gaap:CommonStock0.0

us-gaap:RetainedEarnings


None
Period End2020-06-30
Value0.0
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue0.0
Percentage of Assets0.0
Percentage of Assets us-gaap:RetainedEarnings0.0

None

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-20042000.0-31447000.0-20262000.0-20455000.0-19914000.0-21531000.0-16244000.027692000.0-16648000.0-16933000.0-13270000.0-12169000.0
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-122.8-675.7-520.9-1615.7-1696.3-1460.7-1374.311635.30.00.00.00.0

None

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value35445.9-39.611-12.3412732-122.0433.1491.0121212
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax215.5951.0151.7-3128.8-1051.21890.52757.4-51278.60.00.00.00.0

None

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1590.0750.01284440.897-0.013115-0.804-1.339
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax978.01.60.36642.33803.560.9-1.148646.60.00.0

None

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value17412-14.3524127.2321621-14.303-17.26410.508
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1070.7276.9-368.91897.81056.0490.61382.09003.40.00.00.00.0

None

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-20.042-31.447-20.262-20.455-19.914-21.531-16.24427-16.648-16.933-13.27-12.169
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-122.8-675.7-520.9-1615.7-1696.3-1460.7-1374.311635.30.00.00.00.0

None

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-36288000.0-14282000.0-31036000.0-21227000.0-27832000.0-33198000.0-6037000.0-42646000.0-27503000.0-21209000.0-16091000.0-18465000.0-17933000.0-13954000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-222.4-306.9-797.8-1676.7-2370.7-2252.2-510.7-17918.50.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AdditionalPaidInCapital0.0

us-gaap:CommonStock


None
Period End2020-06-30
Value0
Percentage of NetIncomeLoss-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CommonStock0.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-36288000.0-14282000.0-21227000.0-27832000.0-33198000.0-42646000.0-27503000.0-21209000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-222.4-306.9-1676.7-2370.7-2252.2-17918.50.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.0

None

us-gaap:DepreciationDepletionAndAmortization

us-gaap:DepreciationDepletionAndAmortization


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value4266000.01351000.01781000.0991000.0935000.01025000.0918000.0500000.0900000.0536000.0451000.0400000.0500000.0
Percentage of DepreciationDepletionAndAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value6.0143.1722.9262.8993.551.9591.641.4352.8751.3832.3770.511
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value35445.9-39.611-12.3412732-122.0433.1491.0121212
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax215.5951.0151.7-3128.8-1051.21890.52757.4-51278.60.00.00.00.0

None

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value2121000.02325000.01296000.0448000.0754000.01039000.01013000.0810000.01851000.02906000.02155000.0291000.0
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1590.0750.01284440.897-0.013115-0.804-1.339
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax978.01.60.36642.33803.560.9-1.148646.60.00.0

None

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312016-12-31
Value10108.6463788.5685068.548668.0120296.2360066.2415846.0934084.3649160.209797
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312016-12-31
Value8.377.978.068.048.037.867.787.787.727.174.73
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value273988599756356391832508.7688.2658
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

tbio:AdditionalUpfrontPayment us-gaap:TypeOfArrangement

tbio:AdditionalUpfrontPayment

tbio:SecondSanofiAmendmentAgreement


None
Period End2020-07-20
Value300
Percentage of AdditionalUpfrontPayment100.0

tbio:SecuritiesPurchaseAgreement


None
Period End2020-07-20
Value300
Percentage of AdditionalUpfrontPayment100.0

tbio:CashPaymentOfResearchAndDevelopmentExpense

tbio:CashPaymentOfResearchAndDevelopmentExpense


None
Period End2020-03-31
Value300000.0
Percentage of CashPaymentOfResearchAndDevelopmentExpense100.0

tbio:CashPaymentOfResearchAndDevelopmentExpense us-gaap:TypeOfArrangement

tbio:MitResearchAgreement


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value000300000.02800000.0300000.0900000.0
Percentage of CashPaymentOfResearchAndDevelopmentExpense0.00.00.00.00.00.00.0

tbio:CollaborativeArrangementMilestonePayment us-gaap:TypeOfArrangement, tbio:CollaborativeAgreement

tbio:CollaborativeArrangementMilestonePayment

tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement, tbio:MilestonePaymentOne


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value01375000.00001375000.0
Percentage of CollaborativeArrangementMilestonePayment0.0100.00.00.00.0100.0

tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement, tbio:MilestonePaymentTwo


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value01250000.00001250000.0
Percentage of CollaborativeArrangementMilestonePayment0.090.90.00.00.090.9

tbio:IncreaseDecreaseInLeaseLiability

tbio:IncreaseDecreaseInLeaseLiability


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-134000.0-110000.0-96000.0-74000.0
Percentage of IncreaseDecreaseInLeaseLiability100.0100.0100.0100.0

tbio:IncreaseDecreaseInRightOfUseAssets

tbio:IncreaseDecreaseInRightOfUseAssets


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-138000.0-132000.0-119000.0-115000.0
Percentage of IncreaseDecreaseInRightOfUseAssets100.0100.0100.0100.0

tbio:IncreaseDecreaseInShortTermCollaborationReceivables

tbio:IncreaseDecreaseInShortTermCollaborationReceivables


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-8902000.0-1633000.0659000.0-482000.0
Percentage of IncreaseDecreaseInShortTermCollaborationReceivables100.0100.0100.0100.0

tbio:PaymentsOfAnnualLicenseMaintenanceFees us-gaap:TypeOfArrangement

tbio:PaymentsOfAnnualLicenseMaintenanceFees

tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value200000.0000200000.00100000.00100000.00100000.00
Percentage of PaymentsOfAnnualLicenseMaintenanceFees100.00.00.00.0100.00.0100.00.0100.00.0100.00.0

tbio:StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement us-gaap:TypeOfArrangement

tbio:StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement

tbio:SecuritiesPurchaseAgreement


None
Period End2020-07-20
Value4884400.0
Percentage of StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement100.0

tbio:StockIssuedDuringPeriodSharesNewIssuesPublicOffering us-gaap:StatementEquityComponents

tbio:StockIssuedDuringPeriodSharesNewIssuesPublicOffering

us-gaap:CommonStock


None
Period End2020-06-302019-09-302018-09-30
Value8545000.09000000.09714400.0
Percentage of StockIssuedDuringPeriodSharesNewIssuesPublicOffering100.0100.0100.0

tbio:StockIssuedDuringPeriodValueNewIssuesPublicOffering

tbio:StockIssuedDuringPeriodValueNewIssuesPublicOffering


None
Period End2020-06-302019-09-302018-09-30
Value15384113
Percentage of StockIssuedDuringPeriodValueNewIssuesPublicOffering100.0100.0100.0

tbio:StockIssuedDuringPeriodValueNewIssuesPublicOffering us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-30
Value0.0
Percentage of StockIssuedDuringPeriodValueNewIssuesPublicOffering0.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302019-09-302018-09-30
Value15384113
Percentage of StockIssuedDuringPeriodValueNewIssuesPublicOffering100.0100.0100.0

us-gaap:RetainedEarnings


None
Period End2020-06-30
Value0.0
Percentage of StockIssuedDuringPeriodValueNewIssuesPublicOffering0.0

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value15-9.4523.256-19.8344.88911-14.6267.8524.9087.1836.1322.324
Percentage of BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 us-gaap:ContingentConsiderationByType

tbio:ContingentConsideration


None
Period End2020-06-302020-03-312019-12-31
Value15-9.4523.256
Percentage of BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1100.0100.0100.0

us-gaap:CapitalExpendituresIncurredButNotYetPaid

us-gaap:CapitalExpendituresIncurredButNotYetPaid


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-46000.0764000.01187000.0-57000.0-36000.095000.0-314000.0-126000.0-227000.0716000.0399000.0249000.0
Percentage of CapitalExpendituresIncurredButNotYetPaid100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiabilityRevenueRecognized

tbio:SanofiAgreement


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value5100000.01300000.0500000.0700000.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized100.0100.0100.0100.0

us-gaap:Depreciation

us-gaap:Depreciation


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value700000.0700000.0600000.0600000.0600000.0600000.0500000.0500000.0900000.0500000.0
Percentage of Depreciation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EarningsPerShareBasicAndDiluted


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-0.58-0.24-0.48-0.41-0.57-0.74-0.13-0.97-2.94-2.35-2.04-2.4-2.31-1.86
Percentage of EarningsPerShareBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsPayable


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value6762000.0-9545000.011668000.0118000.0-810000.0-1048000.02251000.0-2674000.0-450000.01531000.02147000.0807000.0
Percentage of IncreaseDecreaseInAccountsPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value3429000.0584000.0-1987000.01644000.0671000.0-71000.0877000.01128000.01670000.0-1404000.0134000.0527000.0
Percentage of IncreaseDecreaseInAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInContractWithCustomerLiability


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value-5.162-1.2670.581-0.432-0.518-0.688-0.349
Percentage of IncreaseDecreaseInContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value5512000.0397000.03710000.03019000.01481000.0285000.0-256000.0-907000.0530000.01979000.01405000.0356000.0
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InvestmentIncomeInterest

us-gaap:InvestmentIncomeInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value343000.0509000.0704000.0428000.0358000.0521000.0824000.0318000.091000.089000.051000.072000.079000.0
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-315000.0114000.062000.0109000.0219000.0155000.0273000.0-76000.00-79000.0-31000.033000.045000.0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-03-31
Value-315000.0114000.0109000.0219000.0155000.0-76000.0-79000.0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-30
Value0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax-0.0

us-gaap:CommonStock


None
Period End2020-06-30
Value0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax-0.0

us-gaap:RetainedEarnings


None
Period End2020-06-30
Value0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax-0.0

us-gaap:PaymentsOfStockIssuanceCosts tbio:AgreementType

us-gaap:PaymentsOfStockIssuanceCosts

tbio:OpenMarketSaleAgreement


None
Period End2020-05-01
Value200000.0
Percentage of PaymentsOfStockIssuanceCosts100.0

us-gaap:PaymentsOfStockIssuanceCosts us-gaap:SubsidiarySaleOfStock

us-gaap:PrivatePlacement


None
Period End2020-05-052019-05-03
Value200000.0600000.0
Percentage of PaymentsOfStockIssuanceCosts0.00.0

us-gaap:ProceedsFromIssuanceOfCommonStock tbio:AgreementType

us-gaap:ProceedsFromIssuanceOfCommonStock

tbio:OpenMarketSaleAgreement


None
Period End2020-05-01
Value37
Percentage of ProceedsFromIssuanceOfCommonStock100.0

us-gaap:ProceedsFromIssuanceOfCommonStock us-gaap:SubsidiarySaleOfStock

us-gaap:PrivatePlacement


None
Period End2020-05-05
Value37
Percentage of ProceedsFromIssuanceOfCommonStock0.0

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value377343602628411.085.09.9181917
Percentage of ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:ProceedsFromStockOptionsExercised


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value5699000.0132000.012000.084000.0519000.0897000.000
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.00.00.0

us-gaap:SaleOfStockConsiderationReceivedOnTransaction us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock

us-gaap:SaleOfStockConsiderationReceivedOnTransaction

tbio:BaupostGroupLlc, tbio:PublicOffering


None
Period End2020-06-302019-09-30
Value1150
Percentage of SaleOfStockConsiderationReceivedOnTransaction100.0100.0

us-gaap:SaleOfStockConsiderationReceivedOnTransaction us-gaap:SubsidiarySaleOfStock, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:PrivatePlacement, tbio:BaupostGroupLlc


None
Period End2020-03-312019-12-31
Value200.0
Percentage of SaleOfStockConsiderationReceivedOnTransaction0.00.0

us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock

us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction

tbio:BaupostGroupLlc, tbio:PublicOffering


None
Period End2020-06-302019-09-30
Value500000.05000000.0
Percentage of SaleOfStockNumberOfSharesIssuedInTransaction100.0100.0

us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction us-gaap:SubsidiarySaleOfStock, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:PrivatePlacement, tbio:BaupostGroupLlc


None
Period End2020-03-312019-12-31
Value2352900.00
Percentage of SaleOfStockNumberOfSharesIssuedInTransaction0.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate us-gaap:TitleOfIndividual, us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

tbio:EmployeesAndDirectors, us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.0060.68-0.001-0.002-0.0060.739-0.001-0.0010.010.747
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate us-gaap:TitleOfIndividual, us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

tbio:EmployeesAndDirectors, us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-0.00070.0086-0.0003-0.0003-0.00050.024700.00010.00070.0273
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate100.0100.0100.0100.0100.0100.00.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value100.10.00.00.20.4-0.1-0.1
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue100.0100.00.00.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value0.834.670.010.020.315.25-0.020.060.355.56-0.08-0.05
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised us-gaap:AwardType

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value776860.015596.01342.010806.066917.0154480.00049459.0000
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0100.0100.0100.0100.00.00.0100.00.00.00.0

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised us-gaap:StatementEquityComponents

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-06-30
Value776860.015596.010806.066917.0154480.049459.0
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueIssuedForServices us-gaap:IncomeStatementLocation

us-gaap:StockIssuedDuringPeriodValueIssuedForServices

us-gaap:ResearchAndDevelopmentExpense


None
Period End2020-06-30
Value2400000.0
Percentage of StockIssuedDuringPeriodValueIssuedForServices100.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-06-30
Value5699000.0132000.084000.0519000.0897000.0278000.0
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-30
Value0
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised0.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-06-30
Value5699000.0132000.084000.0519000.0897000.0278000.0
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.0100.0

us-gaap:CommonStock


None
Period End2020-06-30
Value0
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised0.0

us-gaap:RetainedEarnings


None
Period End2020-06-30
Value0
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised0.0

tbio:AccruedConsultantAndProfessionalFees

tbio:AccruedConsultantAndProfessionalFees


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value2165000.01174000.01390000.01263000.01904000.01299000.0977000.0818000.01130000.0
Percentage of AccruedConsultantAndProfessionalFees100.0100.0100.0100.0100.0100.0100.0100.0100.0

tbio:AccruedExternalResearchAndDevelopmentExpensesCurrent

tbio:AccruedExternalResearchAndDevelopmentExpensesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value2820000.03879000.01763000.04221000.02950000.03247000.01901000.01835000.01132000.01115000.0
Percentage of AccruedExternalResearchAndDevelopmentExpensesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

tbio:AdditionalFeePerAddedPathogenOption us-gaap:TypeOfArrangement

tbio:AdditionalFeePerAddedPathogenOption

tbio:SanofiAgreement


None
Period End2020-06-30
Value5000000.0
Percentage of AdditionalFeePerAddedPathogenOption100.0

tbio:AdditionalUpfrontPaymentReceivable us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement, tbio:AgreementOne, dei:LegalEntity

tbio:AdditionalUpfrontPaymentReceivable

us-gaap:SubsequentEvent, tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreementMember, tbio:SublicenseSecondAmendmentAgreementWithSanofi, tbio:SanofiPasteurInc


None
Period End2020-07-01
Value75
Percentage of AdditionalUpfrontPaymentReceivable100.0

tbio:AdditionalUpfrontPaymentReceivable us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement, tbio:AgreementOne, tbio:SpecificAdditionalMilestonePayment, dei:LegalEntity

us-gaap:SubsequentEvent, tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreementMember, tbio:SublicenseSecondAmendmentAgreementWithSanofi, tbio:SarsCov2LicensedFiled, tbio:SanofiPasteurInc


None
Period End2020-07-01
Value250
Percentage of AdditionalUpfrontPaymentReceivable333.3

tbio:EquityAndDebtSecuritiesAuthorised

tbio:EquityAndDebtSecuritiesAuthorised


None
Period End2020-03-132019-07-03
Value350250
Percentage of EquityAndDebtSecuritiesAuthorised100.0100.0

tbio:MaximumNumberOfInfectiousDisease dei:LegalEntity

tbio:MaximumNumberOfInfectiousDisease

tbio:SanofiPasteurInc


None
Period End2020-06-30
Value10.0
Percentage of MaximumNumberOfInfectiousDisease100.0

tbio:SaleOfStockAuthorizedAmount tbio:AgreementType, us-gaap:Range

tbio:SaleOfStockAuthorizedAmount

tbio:OpenMarketSaleAgreement, srt:Maximum


None
Period End2020-03-13
Value100
Percentage of SaleOfStockAuthorizedAmount100.0

tbio:OpenMarketSaleAgreement, srt:Minimum


None
Period End2020-03-13
Value50
Percentage of SaleOfStockAuthorizedAmount50.0

tbio:SaleOfStockAuthorizedAmount us-gaap:Range, tbio:AgreementType

srt:Maximum, tbio:OpenMarketSaleAgreement


None
Period End2020-03-13
Value100
Percentage of SaleOfStockAuthorizedAmount100.0

srt:Minimum, tbio:OpenMarketSaleAgreement


None
Period End2020-03-13
Value50
Percentage of SaleOfStockAuthorizedAmount50.0

tbio:ShortTermCollaborationReceivablesCurrent

tbio:ShortTermCollaborationReceivablesCurrent


None
Period End2020-06-302020-03-312019-12-312018-12-31
Value156.2284.5960.833
Percentage of ShortTermCollaborationReceivablesCurrent100.0100.0100.0100.0

tbio:UpfrontPaymentsReceived us-gaap:TypeOfArrangement, dei:LegalEntity

tbio:UpfrontPaymentsReceived

tbio:MassachusettsInstituteOfTechnologyExclusivePatentLicenseAgreement, tbio:SanofiPasteurInc


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-07-31
Value0.70.70.70.70.745
Percentage of UpfrontPaymentsReceived100.0100.0100.0100.0100.0100.0

us-gaap:AlternativeInvestmentMeasurementInput us-gaap:ContingentConsiderationByType

us-gaap:AlternativeInvestmentMeasurementInput

tbio:ContingentConsideration


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value14.513.513.513.513.514.5
Percentage of AlternativeInvestmentMeasurementInput100.0100.0100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AssetsFairValueDisclosure

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-06-302017-12-31
Value19153564817231128
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.00.00.0

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:USGovernmentCorporationsAndAgenciesSecurities, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:USGovernmentCorporationsAndAgenciesSecurities, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value20571041117188
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.0

us-gaap:USGovernmentCorporationsAndAgenciesSecurities, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:MoneyMarketFunds, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value191535648175223241128
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.00.00.00.00.0

us-gaap:USGovernmentCorporationsAndAgenciesSecurities, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value20571041117160881229.997
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.00.00.00.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-06-302017-12-31
Value211111160160891121238
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.00.00.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value211111160160891121121461238
Percentage of AssetsFairValueDisclosure0.00.00.00.00.00.00.00.00.00.0

us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:BusinessCombinationContingentConsiderationLiability


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value109941031001201151031189381
Percentage of BusinessCombinationContingentConsiderationLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value109941031001201151031189179
Percentage of BusinessCombinationContingentConsiderationLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance us-gaap:PlanName

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

tbio:TwoThousandEighteenStockIncentivePlan


None
Period End2020-03-312019-12-312019-09-302019-06-302019-01-012018-06-302017-12-31
Value7.2433994.8298474.8205614.7656634.7187333232
Percentage of CommonStockCapitalSharesReservedForFutureIssuance100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiability


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value36424342434344
Percentage of ContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiabilityNoncurrent

us-gaap:ContractWithCustomerLiabilityNoncurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value9.81815253034384144
Percentage of ContractWithCustomerLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value3244000.02298000.03547000.03283000.02392000.01775000.02933000.02951000.01940000.02252000.0
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value7003000.03439000.02747000.01588000.01212000.0862000.0397000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType

tbio:ShiresMrtProgram, us-gaap:InProcessResearchAndDevelopment, tbio:CysticFibrosis


None
Period End2020-06-30
Value0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization0.0

tbio:ShiresMrtProgram, us-gaap:InProcessResearchAndDevelopment, tbio:MrtProduct


None
Period End2020-06-302019-12-31
Value7003000.02747000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:BusinessAcquisition

us-gaap:InProcessResearchAndDevelopment, tbio:MrtProduct, tbio:ShiresMrtProgram


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value3439000.02747000.01588000.01212000.0397000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:IntangibleAssetsGrossExcludingGoodwill


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value8888106106106106106
Percentage of IntangibleAssetsGrossExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:ContingentConsiderationByType

us-gaap:LiabilitiesFairValueDisclosure

tbio:ContingentConsideration


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value1099410310012011510311881
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:ContingentConsiderationByType, us-gaap:MeasurementInputType

tbio:ContingentConsideration, tbio:EarnoutPayments


None
Period End2020-06-302019-12-312018-12-312017-12-31
Value101969472
Percentage of LiabilitiesFairValueDisclosure92.792.791.790.0

tbio:ContingentConsideration, tbio:MilestonePayments


None
Period End2020-06-302019-12-312018-12-312017-12-31
Value7.987.5588.6436.817
Percentage of LiabilitiesFairValueDisclosure7.37.38.38.4

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, tbio:ContingentConsideration, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of LiabilitiesFairValueDisclosure0.0

us-gaap:FairValueInputsLevel2, tbio:ContingentConsideration, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of LiabilitiesFairValueDisclosure0.0

us-gaap:FairValueInputsLevel3, tbio:ContingentConsideration, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302019-12-31
Value109103
Percentage of LiabilitiesFairValueDisclosure100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of LiabilitiesFairValueDisclosure0.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-30
Value0.0
Percentage of LiabilitiesFairValueDisclosure0.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-06-302017-12-31
Value109941031001201039381
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.00.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

tbio:ContingentConsideration, us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value94103100120103
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByLiabilityClass, us-gaap:FairValueByMeasurementFrequency

tbio:ContingentConsideration, us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value1099410310012011510311881
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value109941031001201151031189381
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.00.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:MeasurementInputType, us-gaap:ContingentConsiderationByType

tbio:EarnoutPayments, tbio:ContingentConsideration


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value8796931101069410972
Percentage of LiabilitiesFairValueDisclosure92.492.792.792.192.191.792.290.0

tbio:MilestonePayments, tbio:ContingentConsideration


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value7.1497.5587.3219.4639.0558.6439.2066.817
Percentage of LiabilitiesFairValueDisclosure7.67.37.37.97.98.37.88.4

us-gaap:RestrictedCashCurrent

us-gaap:RestrictedCashCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value950000.0950000.0950000.0950000.0950000.01025000.01025000.01025000.01966000.01966000.01966000.02310000.02235000.0
Percentage of RestrictedCashCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:SaleOfStockPricePerShare us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsidiarySaleOfStock

us-gaap:SaleOfStockPricePerShare

tbio:BaupostGroupLlc, tbio:PublicOffering


None
Period End2020-06-302019-09-30
Value22.010.0
Percentage of SaleOfStockPricePerShare100.0100.0

us-gaap:SaleOfStockPricePerShare us-gaap:SubsequentEventType, dei:LegalEntity

us-gaap:SubsequentEvent, tbio:SanofiPasteurInc


None
Period End2020-07-20
Value25.59
Percentage of SaleOfStockPricePerShare0.0

us-gaap:SaleOfStockPricePerShare us-gaap:SubsidiarySaleOfStock

tbio:PublicOffering


None
Period End2020-06-302019-09-20
Value22.010.0
Percentage of SaleOfStockPricePerShare100.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

us-gaap:RestrictedStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312016-12-31
Value1691.06763.034168.072677.0119990.0168760.0219150.0290270.0368880.0526480.0986890.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

us-gaap:RestrictedStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312016-12-31
Value1.281.281.281.281.281.281.271.231.191.141.1
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value100223.6871639181.10413300.977
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

us-gaap:EmployeeStockOption


None
Period End2020-06-302019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value108.5685068.548668.0120296.2360066.2415846.0934084.364916
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber us-gaap:RelatedPartyTransactionsByRelatedParty

tbio:EvpAndFounder


None
Period End2020-06-30
Value0.176266
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1.7

Line plots across dimensions of each concept


us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities
(None,)
None
us-gaap:ResearchAndDevelopmentExpense
us-gaap:TypeOfArrangement
(None,)
None
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
None
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
None
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
None